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ABSTRACT
Purpose The aim of this study was to introduce a smart and
responsive drug carrier for Doxorubicin (DOX) and Paclitaxel
(PAX) for desirable therapeutic application.
Method Loading and releasing of DOX and PAX from
smart and pH-sensitive functionalized single-walled carbon
nanotube (SWCNTs) and graphene carriers have been simu-
lated by molecular dynamics. The influences of chitosan poly-
mer on proposed carriers have been studied, and both carriers
were functionalized with carboxyl groups to improve the load-
ing and releasing properties of the drugs.
Results The results showed that DOX could be well adsorbed
on both functionalized SWCNTs and graphene. In contrast,
there was a weak electrostatic and Van der Waals interaction
between both these drugs and carriers at cancerous tissues,
which is highly favorable for cancer therapy. Adding trimethyl
chitosan (TMC) polymer to carriers facilitated DOX release
at acidic tissues. Furthermore, at blood pH, the PAX loaded
on the functionalized SWCNTs carrier represented the high-
est dispersion of the drug while the DOX-graphene showed
the highest concentration of the drug at a point. In addition,
the mean-square displacement (MSD) results of PAX-
graphene indicated that the PAX could be adsorbed quickly
and be released slowly. Finally, functionalized graphene-
TMC-PAX is a smart drug system with responsive behavior
and controllable drug release, which are essential in cancer
therapy.
Conclusion Simultaneous application of the carboxyl group
and TMC can optimize the pH sensitivity of the SWCNTs
and graphene to prepare a novel and smart drug carrier for
cancer therapy.
KEY WORDS cancer therapy . graphene . molecular
dynamic . nanomedicine . single walled carbon nanotube
INTRODUCTION
Many new cases of cancers are being reported by the World
Health Organization annually and many different efforts have
been made to cure or prevent the disease (1). However, for most
patients, the local invasion and distant metastasis are often avail-
able and only a few patients have the chance to receive early
diagnosis and treatment (2). As chemotherapy drugs target all rap-
idly dividing cells, including both healthy and cancerous cells, they
can cause severe side effects too. Hence, considering the newly
developed methods to detect cancer at early stages and targeted
drug delivery to cancerous cells without impacting healthy cells
would be desirable. Recently, the biomedical field using nanoma-
terials has gained wide applications in early disease diagnosis and
effective drug delivery into the purposed cells (3–6). In this regard,
Carbon Nanotubes (CNTs) have been extensively for various
applications due to their tunability characteristic, which can also
cross the cell membranes (7–11). Over the last few decades,
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numerousmethods of modifying CNTs have been used in cellular
therapy, drug delivery, and sensors for detecting specific proteins
and other biomolecules in serum. Functionalized carbon nano-
tubes (f-CNTs) have become the sites of interest (12,13) in recent
researches. Graphene has also been reported as a promising ma-
terial for various applications ranging from quantum physics, ca-
talysis, and engineering of nanocomposites nanoelectronics to en-
ergy research and biomaterials (14–17). In a nanomedicine realm,
graphene and its composites can be employed in different appli-
cations including a new generation of biosensors, nanocarriers for
drug delivery, and probes for cell and biological imaging
(15,18–20). During the last two decades, different nanomaterials
of various shapes and chemical compositions, including metal and
metal oxide nanoparticles, polymeric micelles, liposomes, den-
drimers, and carbon nanotubes, have been studied as nano-
carriers for drug delivery (21–24).
Doxorubicin (DOX) and paclitaxel (PAX) are two main
anticancer drugs that can be used in cancer chemotherapy
(25,26) to heal a wide range of cancers in the lung, breast,
and ovaries (27,28). In recent researches, the coupling of the
DOX and PAX has shown advantageous combinational ther-
apy. The importance of performing theoretical studies before
the experiments has become widespread, and they should be
done to ensure the efficiency and reduce the side effects ac-
companied by various drug systems. It is clear that the prop-
erties of carbonaceous materials, such as single-walled carbon
nanotubes (SWCNTs) can be improved and tuned through
applying various functionalizing agents or dopants which has
enabled the researchers to develop novel carbon nanostruc-
tures with optimized performance. Furthermore, the carbon
nanomaterials can respond to specific conditions through
which a smart material can be developed (29,30).
Fig. 1 Structure of the SWCNT based drug nanosystem (a) before and (b) after simulation at the neutral pH. Structure of graphene-based drug nanosystem (c)
before and (d) after simulation at the neutral pH.
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It is well established that simulations can be highly useful in
developing novel and smart nanomedicine systems. In this
regard, many efforts have been devoted to exploiting
Molecular Dynamics (MD) (31–35), Density Functional
Theory(DFT) (36), and Machine Learning (37–39) in discov-
ering emerging and smart drug nanocarriers. Shariatinia and
Mazloom-Jalali (40) perused the graphene containing chitosan
as a carrier of anticancer ifosfamide drug through MD, in
which, the N-doped graphene/chitosan was suggested as an
effective drug carrier. Furthermore, Shang et al. (32) investi-
gated the effect of Zn on the DOX adsorption capacity of
hydroxyapatite. The MD simulations clarified that Zn-
doping can enhance the DOX adsorption capacity of the hy-
droxyapatite. These studies showed that MD calculations
could be performed to even propose smart nanocarbon based
drug carriers, which are pH and temperature-sensitive and
can provide precise loading and controllable release of the
drugs to the targeted tissue (41). Herein, a MD study was
conducted to develop smart and responsive drug delivery sys-
tems. In this regard and to induce a smart behavior, trimethyl
chitosan (TMC) and carboxyl groups have been used as a
grafting and functionalizing agents, respectively, for the co-
adsorption and targeted delivery of DOX and PAX by
SWCNTs and graphene to the cancerous cells.
MATERIALS AND METHODS
Force Fields
The precision and validity of simulation results in MD can be
achieved by using Force Fields. Changing the distances of
inter-particles will cause the Interactive energies (potential en-
ergy) changes. The potential function is presented by Eq. (1).
Moreover, the force function of each i atom in an N-atom
system can be obtained from Eq. (2) which is extracted from
the potential function. These equations are solved at the same
time. Besides, the force is specified to time and the atomic
position by using Eq. (3) (42,43). Simple potentials such as
the hard-sphere potential can be employed for primary mo-
lecular simulation. It is assumed that the particles with a con-
stant velocity move in straight lines. As the distance of a sphere
equals to the sum of their radii, relatively elastic collisions are
going to happen.
According to the principles of conservation of linear mo-
tion size, a new velocity will be calculated. By using the hard-
sphere model, proper results can be obtained, although it is
not ideal in atomic or molecular system simulations. As inter-
atomic or intermolecular distances vary, based on the Van der
Waals potential, their forces change. Eq. (4) represents the
Fig. 2 Electrostatic and Van der Waals energies of (a) DOX–SWCNTs and (b) DOX–graphene interactions versus time at neutral pH; and Electrostatic and Van
der Waals energies of (c) DOX–SWCNTs and (d) DOX–graphene interactions versus time at acidic pH.
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Van der Waals potential, where σ indicates the potential well
depth, and q denotes the distance at which the potential
becomes zero. The distance between two atoms is shown by
r, and their interatomic potential is illustrated by V (44):







¼ Fi; i ¼ 1;…;N ð3Þ
Equations (5) and (6) can be utilized to calculate the drug
diffusion coefficient. Mean-square displacement (MSD) was
considered to determine the drug diffusion coefficient; in
which the coordinates of the atoms are also given as r while t
implies the time. By using Einstein’s relation (Eq. (6)), the
diffusion coefficient can be calculated for the three-
dimensional system, after calculating MSD (45,46):















In this work, GROMACS open source software was used
in the drug simulation.
System Preparation
In this paper, we will explore the effects of functionalizing the
SWCNTs and graphene and grafting TMC polymer in co-
adsorption and controllable co-release of two main anti-cancer
drugs; namely DOX and PAX. In this simulation, SWCNTs
and graphene surface was functionalized with carboxyl groups
to promote the drug loading (at neutral pH, equivalent to blood
condition) on the carrier and controlled releasing (at acidic pH,
equivalent to the cancerous tissues) the drug. There are two
major purposes in functionalizing the surface of SWCNTs and
graphene with carboxyl groups. First of all, a strong electrostatic
interaction between carriers and the drugs will be achieved by
functionalizing the surface using the carboxyl group. There are
amine groups with positive surface charges in the DOX struc-
ture, which lead to a strong electrostatic interaction between
carriers and the drugs when they are exposed to carboxyl groups
with negative surface charges. Accordingly, the drug can be
Fig. 3 Electrostatic and Van der Waals energies of (a) PAX–SWCNTs and (b) PAX–graphene interactions versus time at neutral pH; electrostatic and Van der
Waals energies of (c) PAX–SWCNTS and (d) PAX–graphene interactions versus time at acidic pH.
(4)
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adsorbed on the carrier strongly. At acidic pH, the carboxyl
groups have no surface charge, and the electrostatic interaction
will be decreased. In fact, blood has neutral pH while the cancer
tissues have acidic pH, so it seems to be necessary to have a
carrier with a strong electrostatic interaction at blood pH to have
easy adsorption of the drug at neutral pH; on the contrary, to
ease the controllable release of the drug at acidic pH (cancerous
tissues), the carrier should not possess electrostatic interactions at
pH values of about 5.5. The second main role of the carboxyl
group belongs to their polar property that can modify the hydro-
philicity of the carrier to prevent drug accumulation in the blood.
Furthermore, TMC was used to improve the hydrophilicity and
solubility of the carbon-based carriers. Also, TMC can facilitate
the release of the drug in cancerous tissues. SWCNTs and gra-
phene surface was covered with carboxyl groups in both proton-
ated and deprotonated modes. In doing so, zero surface charge
was regarded while using the optimized potentials for liquid sim-
ulations all atoms (OPLSaa) force field. Charge and other rele-
vant parameters of the nanostructure functional groups were
specified based on similar structures available in the OPLSaa
force field. For determination of non-bonded interactions (i.e.,
electrostatic and Van der Waals), Lenard-Jones and Columbian
potential models were used.
All molecules were placed in the box, and the tip3p water
model was employed as a solvent to achieve molecules
parameters. To minimize the energy of all simulation systems,
5000 steps were implemented. In the next stage, to elevate the
temperature of the system from 0 to 310 K in 100 ps in constant
volume, the Nose–Hoover algorithmwas used. Then, the system
was balanced at a constant pressure in 200 ps. For system pres-
sure balance, the Parrinello–Rahman algorithm was employed.
The MD simulation was done at a temperature of 37°C for
50 ns. The cut-off distance was considered to 1.2. By using par-
ticle mesh ewald (pme), the electrostatic calculation was con-
ducted. The linear constraint solver algorithm was applied for
maintaining the bond lengths; the calculations were accelerated
by implementing the SHAKE algorithm to limit the bonds en-
gaged in the hydrogen atom. Composition of the drug nano-
systems considered in the simulations along with the structures
after performing the simulations (at neutral pH, adsorption) are
shown in Fig. 1.
RESULTS AND DISCUSSION
DOX–SWCNTs and DOX–Graphene Interactions
Van der Waals and electrostatic interactions between DOX-
SWCNTs and DOX-graphene at the releasing and adsorp-
tion pH are indicated in Fig. 2. At neutral pH, according to
Fig. 4 Electrostatic and Van der Waals energies of (a) DOX–TMC-SWCNTS and (b) DOX–TMC-graphene interactions versus time at neutral pH; Electrostatic
and Van der Waals energies of (c) DOX–TMC-SWCNTs and (d) DOX–TMC-graphene interactions versus time at acidic pH.
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Fig. 2(a) a strong electrostatic interaction around 4000 (kJ/
mol) was observed between the DOX and the functionalized
SWCNTs as a carrier. Indeed, the positive surface charge of
the amine groups in the DOX structure was attracted by
the negative surface charge of carboxyl groups in the function-
alized SWCNTsʼ structure. Moreover, the DOX and func-
tionalized graphene illustrated obvious adsorption at the neu-
tral condition, which is related to the surface charge of func-
tionalized graphene and amine groups of theDOX, as evident
in Fig. 2(b). At acidic pH, carboxyl groups had no surface
charge; therefore, both carriers indicated a weak interaction
with the drug and a slow release, as shown in Fig. 2 (c,d). The
reports of the study at neutral pH indicated a strong adsorp-
tion affinity by the carriers in which the carboxyl groups had
negative surface charge, and DOX contained amine groups
with positive surface charge.
PAX–SWCNTs and PAX–Graphene Interactions
Figure 3 illustrates Van der Waals and electrostatic interac-
tions between PAX-SWCNTS and PAX-graphene at releas-
ing and adsorption pH. As it can be observed in Fig. 3, both
drugs had a weak Van derWaals and electrostatic interactions
at both acidic and neutral pH. In essence, PAX had no surface
charge in its structure and in comparison with DOX that
contained Amine groups with positive surface charge, PAX
could not be adsorbed on the functionalized SWCNTs and
graphene with carboxyl groups. According to Fig. 3 (c,d),
PAX could be released slowly from SWCNTs and graphene
carriers.
DOX–TMC Interactions in DOX–TMC-SWCNTs
and DOX–TMC-Graphene
It is proved that TMC can enhance the hydrophilicity
and biocompatibility of different structures (47,48). To
improve the hydrophilicity and biocompatibility of the
carriers, TMC was added to the carriers. The electro-
static and Van der Waals interactions between DOX and
TMC in the mixtures of DOX–TMC-SWCNTs and
DOX–TMC-graphene at adsorption and releasing con-
ditions are shown in Fig. 4. Based on Fig. 4 (a, b), there
was a weak interaction between TMC and DOX in these
systems at neutral pH. On the other hand, adding TMC
to these carriers led to an increase in the drug release
rate at acidic pH to approximately 5000 (kJ/mol),
according to Fig. 4 (c,d), which is not appropriate in
the drug delivery.
Fig. 5 Electrostatic and Van derWaals energies of (a) PAX–TMC-SWCNTs and (b) PAX–TMC-graphene interactions versus time at neutral pH; Electrostatic and
Van der Waals energies of (c) PAX–TMC-SWCNTs and (d) PAX–TMC-graphene interaction versus time at acidic pH.
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PAX–TMC Interactions in PAX–TMC-SWCNTs
and PAX–TMC-Graphene
The influences of adding TMC to the mixtures of PAX-
SWCNTs and PAX-graphene are displayed in Fig. 5. An
extraordinary augment in the electrostatic energy between
PAX and TMC in the mixtures of PAX–TMC-SWCNTs
and PAX–TMC-graphene can be observed in Fig. 5 (a,b) that
attest to the fact that the addition of TMC can assist in the
drug adsorption at neutral pH. Moreover, PAX could be re-
leased gradually, as can be observed in Fig. 5 (c,d) that verifies
the appropriate release pattern of PAX from both mixtures.
Hydrogen Bonds in DOX–SWCNTs
and DOX–Graphene
Figure 6 shows the number of hydrogen bonds between the
DOX and two different functionalized carriers at acidic and
neutral pH. As it is indicated in Fig. 6 (a,b), the number of
hydrogen bonds between the DOX and functionalized gra-
phene was more than that of the functionalized SWCNTs at
the adsorption condition. The main reason for the mentioned
issue belongs to the spatial blockage of the drug and
SWCNTs, which is referred to the electrostatic interaction
between amine and carboxyl groups. There were a few hy-
drogen bonds betweenGO andDOX. Actually, graphene is a
flat sheet in which the atoms can interact with the DOX atoms
from the lower and upper surfaces of graphene, and it had a
lower blockage spatial in comparison with SWCNTs, which
has a cylindrical shape. Furthermore, both carriers were hy-
drophobic, and even adding carboxyl groups to the SWCNTs
structure could not help to form the hydrogen bonds between
SWCNTs and the drug. At acidic pH (Fig. 6 (c,d)), the num-
ber of hydrogen bonds in both carriers was increased because
the spatial hindrance initiated from the carboxyl group of the
functionalized carriers and amine group in DOX structure
was declined. In fact, the carboxyl group had no surface
charge at acidic pH, and there was a low electrostatic interac-
tion between the DOX and these carriers, which led to a
reduction of the spatial hindrance; thus, more hydrogen bonds
could be observed at acidic pH.
Hydrogen Bonds in PAX–SWCNTs and PAX–Graphene
The hydrogen bonds between the PAX and the proposed
nanocarriers are illustrated in Fig. 7. According to Fig. 7
Fig. 6 The number of hydrogen bonds between DOX and (a) SWCNTs and (b) graphene versus time at neutral pH; The number of hydrogen bonds between
DOX and (c) SWCNTs and (d) graphene versus time at acidic pH.
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(a,b) at neutral pH, there were no hydrogen bonds between
PAX and both carriers, which mentions the spatial blockage
that was originated from the strong adsorption of DOX on
these carriers. Indeed, at neutral pH, there was a significant
electrostatic interaction the between amine groups of the
DOX and carboxyl groups in functionalized structures of
SWCNTs and graphene. Amine groups with positive surface
charge were adsorbed considerably by the carboxyl groups in
the structures of the carriers, which led to a remarkable spatial
hindrance, so there were no hydrogen bonds at neutral pH. At
acidic pH, the carboxyl groups of the functionalized
SWCNTs and graphene had no surface charge, so the elec-
trostatic interactions between the DOX and these functional-
ized carriers were declined. Therefore, approximately two
hydrogen bonds could be seen between PAX and these car-
riers (Fig. 7 (c,d)).
Hydrogen Bonds between DOX and TMC
in DOX-TMC-SWCNTs and DOX-TMC-Graphene
The addition of the TMC to the structures of functionalized
SWCNTs and graphene improved the hydrophilicity and bio-
compatibility of these carries. The presence of the TMC in the
structures of the carriers resulted in the higher number of
hydrogen bonds at adsorption condition between DOX and
TMC (Fig. 8 (a,b)). Based on Fig. 8 (a,b), the average number
of hydrogen bonds between the DOX and TMC was around
two. Besides, at acidic conditions, there were almost two hy-
drogen bonds between the DOX and TMC for the mixtures
of DOX-TMC-SWCNTs and DOX-TMC-graphene (Fig.
8 (c, d)). Accordingly, adding the TMC to the mixtures of
these carriers, in addition to enhancing the hydrophilicity of
these carries, could provide more hydrogen bonds of DOX
with SWCNTs and graphene.
Hydrogen Bonds between PAX and TMC
in PAX-TMC-SWCNTS and PAX-TMC-Graphene
Figure 9 demonstrates the number of hydrogen bonds between
PAX and TMC in the structures of functionalized SWCNTs
and graphene. As it is reflected in Fig. 9 (a, b), at neutral pH
the average number of hydrogen bonds between the PAX and
TMC in the mixtures of PAX-TMC-SWCNTs and PAX-
TMC-graphene was around three, which is related to the polar
structure of TMC that can provide the conditions for forming
the hydrogen bonds. In addition, at the releasing pH, the num-
ber of hydrogen bonds between the TMC and PAX in these
mixtures was approximately in the range of 2–3 (Fig. 9 (c, d)).
Fig. 7 The number of hydrogen bonds between the DOX and (a) SWCNTs and (b) graphene versus time at neutral pH; The number of hydrogen bonds
between the PAX and (a) SWCNTs and (d) graphene versus time at acidic pH.
  160 Page 8 of 13 Pharm Res          (2020) 37:160 
Gyration Radii of DOX-TMC-SWCNTs
and PAX-TMC-Graphene
Figure 10 indicates the gyration radii of the DOX and
PAX in SWCNTs and graphene carriers at neutral and
acidic pH. The gyration radius is a factor for evaluation
of the size change of bio-macromolecules (such as pro-
teins) and aggregation of the molecules (such as polymers).
When the decrease of gyration radius is higher, the more
stable carrier will be obtained and a more strong interac-
tion between carriers and the drugs will be achieved.
According to the relative curve of the PAX and DOX in
Fig. 10 (a), the decrease of radius gyration of the PAX was
higher than DOX and it shows that SWCNTs could be a
more stable carrier for PAX at neutral pH. In addition, as
can be seen in Fig. 10 (b) at neutral pH, the reduction of
radius gyration for the PAX and graphene was higher
than that of the DOX and graphene; so, it can be stated
that the graphene can be a more stable carrier for the
PAX. At the releasing pH, based on the relative curve
of the PAX for both carriers, graphene was a more stable
carrier (Fig. 10 (c, d)).
Radial Distribution of DOX and PAX in TMC-SWCNTs
and TMC-Graphene
Figure 11 exhibits the molecular dispersion of the DOX and
PAX in the mixtures of TMC-SWCNTs and TMC-graphene
at neutral and acidic pH, respectively. In this figure, a sharper
curve is attributed to the concentration of drug molecules and
the carrier at one point. As can be observed in Fig. 11, the
DOX represented a higher radial distribution in comparison
with the PAX in the mixtures of both carriers at both acidic
and neutral pH. According to Fig. 11 (a, b), the DOX had a
higher RDF value in the mixture of DOX-SWCNTs, which
was about 0.8. The higher value of RDF can be related to
better adsorption; thus, based on Fig. 11 (a) it is proved that
DOX-SWCNTs had a stronger electrostatic interaction at
blood pH and more proper adsorption could occur. At acidic
pH, the DOX with both carriers led to a sharper curve and is
understood that the molecules of the drug and carrier were of
a higher concentration at one point. Thereafter, in the mix-
tures of DOX-graphene and DOX-SWCNTs, the DOX
reflected a higher aggregation in comparison with the PAX.
Furthermore, at the releasing condition, the maximum value
Fig. 8 The number of hydrogen bonds between DOX and TMC in (a) DOX-TMC-SWCNTs and (b) DOX-TMC-graphene versus time at neutral pH; The
number of hydrogen bonds between DOX and TMC in (c) DOX-TMC-SWCNTs and (d) DOX-TMC-graphene versus time at acidic pH.
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of the RDF was around four, which belongs to the DOX-
graphene, however, the PAX-SWCNTs had the minimum
RDF value of approximately 1.5.
Mean Square Displacement (MSD) of DOX-SWCNTs
and PAX-SWCNTS
Mean Square Displacement (MSD) of DOX-SWCNTs and
PAX-SWCNTS at neutral and acidic pH values are shown in
Fig. 12. As it is clear in the figure, at neutral pH, theMSDwas
higher, which implies that the drug could be absorbed more
quickly by the carrier; in contrast, the drug could be released
from the carrier more slowly in the less MSD values. In fact,
the longer half-life corresponds to the less MSD value, where
the drug will be released from the carrier slower. In this figure,
the slope of the graph shows the diffusion coefficient.
According to Fig. 12(a) at adsorption condition, at first all
curves had a slight slope and by passing the time, the slope was
increased. The enhancement of the slope has alluded to the
spatial blockage between the molecules in which after some
seconds, the spatial blockage was reduced and the rate of drug
adsorption on these carriers could be altered. Among all cases
in Fig. 12 (a), the PAX showed a significant adsorption behav-
ior; however, the lowest adsorption rate as achieved for the
DOX on the SWCNTs. Moreover, DOX showed a lower
MSD value for release of PAX-graphene in releasing condi-
tion which means it can be released slower than DOX-
SWCNTS, DOX-graphene and PAX-SWCNTS in the same
condition. In addition, based on Fig. 11(b) the slopes of all
curves were increased gradually, which can confirm that by
passing the time, the spatial obstruction was reduced.
Therefore, the ideal manner of drug adsorption and release
belongs to the PAX-graphene, which is originated from the
Van der Waals energy bonds between the PAX and
Graphene.
CONCLUSION
The side effects of anticancer drugs such as DOX and PAX
will be reduced by developing biocompatibility and solubility
of the drug through adding TMC to the mixture of DOX or
PAX-SWCNTs or graphene and functionalizing the carriers
by carboxyl group. In this MDs study, according to the
Fig. 9 The number of hydrogen bonds between PAX and TMC in (a) PAX-TMC-SWCNTs and (b) PAX-TMC-graphene versus time at neutral pH; The number
of hydrogen bonds between PAX and TMC in (c) PAX-TMC-SWCNTs and (d) PAX-TMC-graphene versus time at acidic pH.
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electrostatic and Van der Waals energy results, at the blood
pH, the DOX could be adsorbed by both functionalized
SWCNTs and graphene and value of the electrostatic energy
was around 6000 kj/mol and both carriers were ideal for the
DOX loading. In addition, the electrostatic and Van der
Waals energy between PAX and both carriers were around
zero and there were no strong electrostatic and Van derWaals
interactions between the PAX and these carriers at both neu-
tral and acidic pH. Using TMC in addition to promoting the
hydrophilicity and biocompatibility of these carriers, could
facilitate the release of the DOX. Moreover, the TMC
had a positive surface charge at acidic pH that was same as
Fig. 10 Gyration radii of DOX and PAX versus time at neutral and acidic pH for DOX and PAX in the mixtures of DOX-TMC-SWCNTs and PAX-TMC-
graphene: (a) SWCNTs at neutral pH; (b) graphene at neutral pH; (c) SWCNTS at acidic pH, and (d) graphene at acidic pH.
Fig. 11 Radial distribution of the DOX and PAX in the mixtures of DOX-TMC-SWCNTs and PAX-TMC-graphene (a) at neutral pH and (b) at acidic pH.
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that of the amine group in DOX, which could facilitate the
release of the drug at acidic condition. Furthermore, the num-
ber of hydrogen bonds between the drugs and carriers was
increased by adding TMC at both acidic and neutral pH
and adding TMC had a positive impact on promoting the
formation of hydrogen bonds. As it was shown by gyration
radius parameter, the highest dispersion at neutral pH was
achieved for the PAX loaded on functionalized SWCNTs
carrier while the DOX-graphene showed the highest concen-
tration of the drug at a point. Overall, it can be stated that the
PAX with functionalized graphene-TMC exhibited a more
stable carrier in comparison with the DOX with the function-
alized SWCNTs-TMC. Based on the MSD results, it was
found that the PAX-graphene had the most proper drug ad-
sorption and release behavior, where the PAX could be
adsorbed quickly and be released slowly, leading to an in-
crease in the drug’s half-life.
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